Mark A. Glickman, Co-Chief Executive Officer at TherapeuticsMD, Inc. (TXMD), sold 440 shares at $4.92 ($2K) on 2022-12-06, disclosed to the SEC on 2022-12-09.
Open-market sale of $2k TXMD by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AUXL | SELL | 2014-11-24 | $1.6M | — | Filing → |